|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 210.00 GBX | +0.48% |
|
-1.87% | +0.96% |
| 03-09 | Hutchmed (China) says Ipsen initiates market withdrawal and recall of Tazverik in China | RE |
| 03-09 | Global markets live: Live Nation, Eli Lilly, Amazon, Microsoft, ABB… |  |
| Capitalization | 2.39B 2.09B 1.89B 1.81B 3.28B 221B 3.41B 22.55B 8.94B 106B 8.97B 8.78B 381B | P/E ratio 2026 * |
46.8x | P/E ratio 2027 * | 41.4x |
|---|---|---|---|---|---|
| Enterprise value | 1.73B 1.51B 1.37B 1.31B 2.38B 160B 2.47B 16.33B 6.47B 76.51B 6.5B 6.36B 276B | EV / Sales 2026 * |
2.66x | EV / Sales 2027 * | 2.33x |
| Free-Float |
57.51% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: HUTCHMED (China) Limited
| 1 day | +0.48% | ||
| 1 week | -1.87% | ||
| Current month | -2.33% | ||
| 1 month | -2.33% | ||
| 3 months | +2.94% | ||
| 6 months | -19.23% | ||
| Current year | +0.96% |
| 1 week | 196.5 |  | 219 |
| 1 month | 196.5 | | 225 |
| Current year | 194 | | 239 |
| 1 year | 185.5 | | 292 |
| 3 years | 173.6 | | 353 |
| 5 years | 130 | | 656 |
| 10 years | 130 | | 656 |
| Manager | Title | Age | Since |
|---|---|---|---|
Chig Fung Cheng
CEO | Chief Executive Officer | 59 | 24/08/2025 |
Michael Shi
CTO | Chief Tech/Sci/R&D Officer | 61 | 31/12/2021 |
Karen Atkin
COO | Chief Operating Officer | 60 | 31/12/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Edith Shih
BRD | Director/Board Member | 74 | 31/12/2005 |
Chig Fung Cheng
BRD | Director/Board Member | 59 | 31/12/2010 |
Wei Guo Su
BRD | Director/Board Member | 68 | 26/03/2017 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -2.46% | 0.01% | 33,076 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.48% | -1.87% | -13.58% | -11.21% | 2.39B | |
| +0.80% | -0.53% | +21.09% | +201.18% | 880B | |
| -0.21% | +0.47% | +48.34% | +56.91% | 582B | |
| -2.52% | -4.53% | +3.74% | +42.79% | 388B | |
| +0.79% | -6.01% | +4.87% | +20.81% | 324B | |
| +0.11% | -0.83% | +19.89% | +34.57% | 295B | |
| +0.43% | -1.54% | +25.96% | +62.12% | 293B | |
| -0.26% | -0.16% | +22.25% | +8.08% | 286B | |
| -0.43% | -0.90% | +16.74% | +58.82% | 197B | |
| +0.42% | +0.74% | +30.11% | +81.76% | 180B | |
| Average | -0.04% | -1.52% | +17.94% | +55.58% | 342.86B | |
| Weighted average by Cap. | -0.02% | -1.37% | +22.82% | +84.75% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 652M 570M 515M 492M 895M 60.26B 931M 6.15B 2.44B 28.79B 2.44B 2.39B 104B | 751M 656M 593M 567M 1.03B 69.47B 1.07B 7.09B 2.81B 33.19B 2.82B 2.76B 120B |
| Net income | 42.03M 36.74M 33.19M 31.75M 57.75M 3.89B 60.03M 397M 157M 1.86B 158M 154M 6.71B | 72.87M 63.7M 57.55M 55.05M 100M 6.74B 104M 687M 272M 3.22B 273M 268M 11.63B |
| Net Debt | -658M -576M -520M -497M -905M -60.9B -940M -6.21B -2.46B -29.1B -2.47B -2.42B -105B | -641M -560M -506M -484M -881M -59.3B -916M -6.05B -2.4B -28.33B -2.41B -2.35B -102B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/03/26 | 210.00 p | +0.48% | 13,450 |
| 12/03/26 | 209.00 p | -4.13% | 7,931 |
| 11/03/26 | 218.00 p | +1.87% | 73,595 |
| 10/03/26 | 214.00 p | +0.94% | 12,639 |
| 09/03/26 | 212.00 p | -0.93% | 6,364 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- HCM Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition